IL6 and inflammatory bowel disease: This expression pattern seems to overlap with the observed for IL-6, despite the lack of correlation between its mRNA levels, and this suggests the implication of the STAT-3 signaling pathway in the pathogenesis of IBD, with IL-6 acting as activator and SOCS-3 as negative regulator [21].